Nordea Investment Management Ab Myriad Genetics Inc Transaction History

Nordea Investment Management Ab

$85.8 Billion
Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Myriad Genetics Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 153,386 shares of MYGN stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,386

Previous 161,642 5.11%

Holding current value

$2.05 Million

Previous $3.95 Million 6.2%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$23.97 - $28.6 $197,896 - $236,121	-8,256 Reduced 5.11%	153,386 $4.2 Million
Q2 2024 Aug 08, 2024	BUY	$17.98 - $25.47 $588,647 - $833,862	32,739 Added 25.4%	161,642 $3.95 Million
Q1 2024 May 02, 2024	BUY	$17.59 - $23.59 $119,735 - $160,577	6,807 Added 5.58%	128,903 $2.75 Million
Q4 2023 Jan 10, 2024	SELL	$13.91 - $21.32 $72,512 - $111,141	-5,213 Reduced 4.09%	122,096 $2.34 Million
Q3 2023 Nov 13, 2023	SELL	$15.99 - $23.22 $72,498 - $105,279	-4,534 Reduced 3.44%	127,309 $2.04 Million
Q2 2023 Jul 07, 2023	SELL	$17.56 - $23.76 $832,730 - $1.13 Million	-47,422 Reduced 26.45%	131,843 $3.06 Million
Q1 2023 Apr 19, 2023	SELL	$15.26 - $23.75 $42,239 - $65,740	-2,768 Reduced 1.52%	179,265 $4.16 Million
Q4 2022 Feb 08, 2023	SELL	$14.51 - $20.99 $277,082 - $400,825	-19,096 Reduced 9.49%	182,033 $2.64 Million
Q3 2022 Oct 19, 2022	SELL	$18.21 - $27.88 $19,466 - $29,803	-1,069 Reduced 0.53%	201,129 $3.98 Million
Q2 2022 Aug 09, 2022	SELL	$16.45 - $25.88 $358,165 - $563,485	-21,773 Reduced 9.72%	202,198 $3.67 Million
Q1 2022 Apr 11, 2022	BUY	$22.67 - $28.01 $69,120 - $85,402	3,049 Added 1.38%	223,971 $5.78 Million
Q4 2021 Jan 20, 2022	SELL	$24.13 - $32.63 $40,272 - $54,459	-1,669 Reduced 0.75%	220,922 $6.26 Million
Q3 2021 Nov 01, 2021	SELL	$29.97 - $36.66 $6.67 Million - $8.16 Million	-222,591 Reduced 50.0%	222,591 $7.36 Million
Q3 2021 Nov 01, 2021	BUY	$29.97 - $36.66 $6.77 Million - $8.28 Million	225,740 Added 102.87%	445,182 $14.4 Million
Q2 2021 Jul 16, 2021	BUY	$25.39 - $32.61 $2.12 Million - $2.72 Million	83,448 Added 61.36%	219,442 $6.71 Million
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $46,314 - $73,470	-2,325 Reduced 1.68%	135,994 $4.07 Million
Q4 2020 Feb 12, 2021	SELL	$12.16 - $19.77 $44,797 - $72,832	-3,684 Reduced 2.59%	138,319 $2.74 Million
Q3 2020 Nov 09, 2020	SELL	$11.25 - $14.75 $1.6 Million - $2.09 Million	-142,003 Reduced 50.0%	142,003 $1.85 Million
Q2 2020 Aug 13, 2020	BUY	$10.69 - $16.49 $1.55 Million - $2.39 Million	144,820 Added 104.05%	284,006 $3.22 Million
Q1 2020 May 15, 2020	BUY	$9.78 - $29.53 $40,049 - $120,925	4,095 Added 3.03%	139,186 $2.05 Million
Q4 2019 Feb 11, 2020	BUY	$20.93 - $35.1 $85,854 - $143,980	4,102 Added 3.13%	135,091 $3.63 Million
Q3 2019 Nov 13, 2019	BUY	$22.08 - $47.08 $20,291 - $43,266	919 Added 0.71%	130,989 $3.75 Million
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $27,181 - $41,965	-1,199 Reduced 0.91%	130,070 $3.61 Million
Q1 2019 May 20, 2019	BUY	$26.93 - $34.7 $660,108 - $850,566	24,512 Added 22.96%	131,269 $4.36 Million
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $143,611 - $240,283	5,274 Added 5.2%	106,757 $3.1 Million
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $729,496 - $977,451	19,417 Added 23.66%	101,483 $4.67 Million
Q2 2018 Aug 13, 2018	SELL	$27.75 - $40.17 $133,505 - $193,257	-4,811 Reduced 5.54%	82,066 $3.07 Million
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $449,719 - $639,714	15,599 Added 21.88%	86,877 $2.57 Million
Q4 2017 Feb 12, 2018	SELL	$28.45 - $37.14 $196,305 - $256,266	-6,900 Reduced 8.83%	71,278 $2.45 Million
Q3 2017 Nov 09, 2017	BUY	$24.01 - $36.2 $1.88 Million - $2.83 Million	78,178	78,178 $2.83 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Myriad Genetics Inc Transaction History